TLSI Latest Press Releases

-- October 20, 2026 --

TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call Business Wire 4:32 PM

-- September 22, 2026 --

TriSalus Life Sciences Receives FDA Clearance for TriNav Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery (PEDD ) Portfolio for Liver Embolization Business Wire 4:15 PM

-- August 31, 2026 --

TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment Conference Business Wire 4:05 PM

-- August 6, 2026 --

TriSalus Life Sciences Reports Second Quarter 2026 Results Business Wire 4:05 PM

-- July 29, 2026 --

TriSalus Life Sciences to Participate in the Canaccord Genuity 46th Annual Growth Conference Business Wire 4:05 PM

-- July 16, 2026 --

TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call Business Wire 4:05 PM

-- June 23, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI Globe Newswire 5:45 PM

-- June 18, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI PRNewswire 10:02 AM

-- June 16, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI Globe Newswire 5:31 PM

-- June 10, 2026 --

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm Globe Newswire 10:04 AM

TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery in Liver Cancer Business Wire 8:00 AM

-- June 5, 2026 --

TLSI INVESTOR ALERT: Holzer & Holzer, LLC Investigation of TriSalus Life Sciences, Inc. Globe Newswire 11:39 AM

-- June 4, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI PRNewswire 10:08 AM

-- June 3, 2026 --

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm Business Wire 6:00 AM

-- June 2, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI Globe Newswire 4:49 PM

Market Data Delayed 15 Minutes